Influence of Trolox and Quercetin Combinations on Human Ovarian Cancer Cell Line A2780 and Human Breast Cancer Cell Line T47D-KBluc
AbstractOur aim was to investigate whether combining two powerful antioxidants such as Trolox and quercetin could enhance their toxicity against breast and ovarian cancer cells. Human ovarian carcinoma cells from the A2780 line and human mammary gland carcinoma cells belonging to the T47Dkb-luc line were incubated in RPMI-1640 supplemented with 50 ÂµM Trolox and various quercetin concentrations (25 ÂµM, 50 ÂµM and 100 ÂµM). After 24 hours several test were conducted: cells were stained with trypan blue and the number of viable versus dead cells was counted; cells were stained with Hoechst 33258 and propidium iodide to investigate the incidence of apoptosis and necrosis and cell activity and proliferation was assessed using the MTT test. In the A2780 line 50 ÂµM Trolox + 25ÂµM quercetin increased the number of apoptotic cells and enzyme activity in these cells, without influencing viability. On the other hand, in the T47Dkb-luc line the 50 ÂµM Trolox + 100 ÂµM combination enhanced necrosis and thus reduced the percentages of metabolically active cells. Together with this concentration, a mix made of 50 ÂµM Trolox and 25 ÂµM quercetin also reduced cell viability. Our research indicates that in combination with Trolox low concentrations of quercetin induce apoptosis in human ovarian cancer cells while high concentrations induce necrosis in human breast cancer cells. Quercetin concentrations influence this response significantly. Combining quercetin with Trolox can enhance their toxicity against breast and ovarian cancer cells
a) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).